255 related articles for article (PubMed ID: 22880087)
41. Repression of MAL tumour suppressor activity by promoter methylation during cervical carcinogenesis.
Overmeer RM; Henken FE; Bierkens M; Wilting SM; Timmerman I; Meijer CJ; Snijders PJ; Steenbergen RD
J Pathol; 2009 Nov; 219(3):327-36. PubMed ID: 19662663
[TBL] [Abstract][Full Text] [Related]
42. Genetic and epigenetic modifications of Sox2 contribute to the invasive phenotype of malignant gliomas.
Alonso MM; Diez-Valle R; Manterola L; Rubio A; Liu D; Cortes-Santiago N; Urquiza L; Jauregi P; Lopez de Munain A; Sampron N; Aramburu A; Tejada-Solís S; Vicente C; Odero MD; Bandrés E; García-Foncillas J; Idoate MA; Lang FF; Fueyo J; Gomez-Manzano C
PLoS One; 2011; 6(11):e26740. PubMed ID: 22069467
[TBL] [Abstract][Full Text] [Related]
43. Sox2 gene amplification significantly impacts overall survival in serous epithelial ovarian cancer.
Belotte J; Fletcher NM; Alexis M; Morris RT; Munkarah AR; Diamond MP; Saed GM
Reprod Sci; 2015 Jan; 22(1):38-46. PubMed ID: 25038052
[TBL] [Abstract][Full Text] [Related]
44. Transcriptional regulation of hTREX84 in human cancer cells.
Guo S; Liu M; Godwin AK
PLoS One; 2012; 7(8):e43610. PubMed ID: 22952718
[TBL] [Abstract][Full Text] [Related]
45. Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo.
Ramachandran I; Thavathiru E; Ramalingam S; Natarajan G; Mills WK; Benbrook DM; Zuna R; Lightfoot S; Reis A; Anant S; Queimado L
Oncogene; 2012 May; 31(22):2725-37. PubMed ID: 22002305
[TBL] [Abstract][Full Text] [Related]
46. FOXP1 functions as an oncogene in promoting cancer stem cell-like characteristics in ovarian cancer cells.
Choi EJ; Seo EJ; Kim DK; Lee SI; Kwon YW; Jang IH; Kim KH; Suh DS; Kim JH
Oncotarget; 2016 Jan; 7(3):3506-19. PubMed ID: 26654944
[TBL] [Abstract][Full Text] [Related]
47. Promoter methylation of p16, DAPK, CDH1, and TIMP-3 genes in cervical cancer: correlation with clinicopathologic characteristics.
Jeong DH; Youm MY; Kim YN; Lee KB; Sung MS; Yoon HK; Kim KT
Int J Gynecol Cancer; 2006; 16(3):1234-40. PubMed ID: 16803511
[TBL] [Abstract][Full Text] [Related]
48. The regulation of MASPIN expression in epithelial ovarian cancer: association with p53 status, and MASPIN promoter methylation: a gynecologic oncology group study.
Alvarez Secord A; Darcy KM; Hutson A; Huang Z; Lee PS; Jewell EL; Havrilesky LJ; Markman M; Muggia F; Murphy SK
Gynecol Oncol; 2011 Nov; 123(2):314-9. PubMed ID: 21903246
[TBL] [Abstract][Full Text] [Related]
49. [Reversal effect of 5-aza-2-deoxycytidine on the maternally expressed gene 3 promoter hypermethylation and its inhibitory effect on the proliferation of epithelial ovarian cancer cells].
Li J; Zhou D; Wang Z; Tan L; Zhou Y; Li J; Sheng X
Zhonghua Zhong Liu Za Zhi; 2015 May; 37(5):324-9. PubMed ID: 26463020
[TBL] [Abstract][Full Text] [Related]
50. Decreased expression of retinoblastoma protein-interacting zinc-finger gene 1 in human esophageal squamous cell cancer by DNA methylation.
Dong SW; Cui YT; Zhong RR; Liang DC; Liu YM; Wang YG; He Z; Wang S; Liang SJ; Zhang P
Clin Lab; 2012; 58(1-2):41-51. PubMed ID: 22372344
[TBL] [Abstract][Full Text] [Related]
51. Promoter hypermethylation profile of ovarian epithelial neoplasms.
Makarla PB; Saboorian MH; Ashfaq R; Toyooka KO; Toyooka S; Minna JD; Gazdar AF; Schorge JO
Clin Cancer Res; 2005 Aug; 11(15):5365-9. PubMed ID: 16061849
[TBL] [Abstract][Full Text] [Related]
52. Methylation of OPCML promoter in ovarian cancer tissues predicts poor patient survival.
Zhou F; Tao G; Chen X; Xie W; Liu M; Cao X
Clin Chem Lab Med; 2014 May; 52(5):735-42. PubMed ID: 24327526
[TBL] [Abstract][Full Text] [Related]
53. In epithelial cancers, aberrant
Thangavelu PU; Krenács T; Dray E; Duijf PH
Clin Epigenetics; 2016; 8():120. PubMed ID: 27891193
[TBL] [Abstract][Full Text] [Related]
54. Serine/threonine kinases 31(STK31) may be a novel cellular target gene for the HPV16 oncogene E7 with potential as a DNA hypomethylation biomarker in cervical cancer.
Yin FF; Wang N; Bi XN; Yu X; Xu XH; Wang YL; Zhao CQ; Luo B; Wang YK
Virol J; 2016 Apr; 13():60. PubMed ID: 27044426
[TBL] [Abstract][Full Text] [Related]
55. Interplay between promoter methylation and chromosomal loss in gene silencing at 3p11-p14 in cervical cancer.
Lando M; Fjeldbo CS; Wilting SM; C Snoek B; Aarnes EK; Forsberg MF; Kristensen GB; Steenbergen RD; Lyng H
Epigenetics; 2015; 10(10):970-80. PubMed ID: 26291246
[TBL] [Abstract][Full Text] [Related]
56. DNA methylation of the RIZ1 tumor suppressor gene plays an important role in the tumorigenesis of cervical cancer.
Cheng HY; Gao Y; Lou G
Eur J Med Res; 2010 Jan; 15(1):20-4. PubMed ID: 20159667
[TBL] [Abstract][Full Text] [Related]
57. Quantitative assessment of AKAP12 promoter methylation in colorectal cancer using methylation-sensitive high resolution melting: Correlation with Duke's stage.
Liu W; Guan M; Su B; Ye C; Li J; Zhang X; Liu C; Li M; Lin Y; Lu Y
Cancer Biol Ther; 2010 Jun; 9(11):862-71. PubMed ID: 20364105
[TBL] [Abstract][Full Text] [Related]
58. Transformation of epithelial ovarian cancer stemlike cells into mesenchymal lineage via EMT results in cellular heterogeneity and supports tumor engraftment.
Jiang H; Lin X; Liu Y; Gong W; Ma X; Yu Y; Xie Y; Sun X; Feng Y; Janzen V; Chen T
Mol Med; 2012 Oct; 18(1):1197-208. PubMed ID: 22801793
[TBL] [Abstract][Full Text] [Related]
59. The role of EZH2 and DNA methylation in hMLH1 silencing in epithelial ovarian cancer.
Wang J; Yu L; Cai J; Jia J; Gao Y; Liang M; Wang Z
Biochem Biophys Res Commun; 2013 Apr; 433(4):470-6. PubMed ID: 23523787
[TBL] [Abstract][Full Text] [Related]
60. Comprehensive methylome analysis of ovarian tumors reveals hedgehog signaling pathway regulators as prognostic DNA methylation biomarkers.
Huang RL; Gu F; Kirma NB; Ruan J; Chen CL; Wang HC; Liao YP; Chang CC; Yu MH; Pilrose JM; Thompson IM; Huang HC; Huang TH; Lai HC; Nephew KP
Epigenetics; 2013 Jun; 8(6):624-34. PubMed ID: 23774800
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
